In this cohort, we found one patient with AML concomitant with CSF3R, IDH2, RUNX1, and WT1 mutations, one patient with CMML concurrent with the MLL‐ELL fusion gene. This evidence concerns the gene KMT2A and acute myeloid leukemia.